Back to search
FDAFDA · Food and drugs·Recall number D-0509-2023

Alprazolam C-IV, 2 mg, 60 Tabs per bottle, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC 72189-121-60.

Published April 12, 2023 · Recall initiated: March 22, 2023

Summary

FDA records drug Class II recall D-0509-2023, published April 12, 2023 and initiated March 22, 2023. Recalling firm: Direct Rx; Status: Ongoing; Reported quantity: 9 bottles; Lot: Lots: 03FE2319 Exp. 2/28/25, 13MY2217 Exp. 5/31/23. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Direct Rx
Distributor
Nationwide in the USA
Lot
Lots: 03FE2319 Exp. 2/28/25, 13MY2217 Exp. 5/31/23
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Alprazolam C-IV, 2 mg, 60 Tabs per bottle, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC 72189-121-60. recalled?

Yes. FDA published recall D-0509-2023 on April 12, 2023. Reported hazard: CGMP Deviations: Repackaging firm recalling due to potential product cross contamination concerns at the manufacturer.

What should I do if I have this product?

Voluntary: Firm initiated · Letter